Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilara Bahceci

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Internal Medicine Journal|July 6, 2023
Can old drugs learn new tricks? Achieving registration and public subsidy listing for off-patent medicines with novel therapeutic applicationsJonathan Brett, Dilara Bahceci, Wendy Lipworth, et al.
Cannabis and Cannabinoid Research|October 21, 2022
Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a <i>Scn1a</i><sup>+/-</sup> Mouse Model of Dravet SyndromeDilara Bahceci, Lyndsey L Anderson, Richard C Kevin, et al.
Scientific Reports|July 23, 2021
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrationsLyndsey L Anderson, Maia G Etchart, Dilara Bahceci, et al.
Epilepsy & Behavior : E&B|December 25, 2019
Adolescent behavioral abnormalities in a Scn1a<sup>+/-</sup> mouse model of Dravet syndromeDilara Bahceci, Lyndsey Leigh Anderson, Cassandra Veronica Occelli Hanbury Brown, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 4, 2017
Interactions between cannabidiol and Δ<sup>9</sup>-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathwayStephanie M Todd, Cilla Zhou, David J Clarke, et al.
The Australian and New Zealand Journal of Psychiatry|October 13, 2023
Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depressionAnthony Rodgers, Dilara Bahceci, Christopher G Davey, et al.
Frontiers in Pharmacology|June 3, 2021
The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the <i>Scn1a</i> <sup></sup> Mouse Model of Dravet SyndromeVaishali Satpute Janve, Lyndsey L Anderson, Dilara Bahceci, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2018
Nrg1 deficiency modulates the behavioural effects of prenatal stress in miceDavid J Clarke, Lala Sarkissian, Stephanie M Todd, et al.
Neuropharmacology|November 25, 2021
The endocannabinoid system impacts seizures in a mouse model of Dravet syndromeLyndsey L Anderson, Peter T Doohan, Nicole A Hawkins, et al.
Drug and Alcohol Dependence|May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international surveyDilara Bahceci, Krista Siefried, Maureen Steele, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Internal Medicine Journal|July 6, 2023
Can old drugs learn new tricks? Achieving registration and public subsidy listing for off-patent medicines with novel therapeutic applicationsJonathan Brett, Dilara Bahceci, Wendy Lipworth, et al.
Cannabis and Cannabinoid Research|October 21, 2022
Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a <i>Scn1a</i><sup>+/-</sup> Mouse Model of Dravet SyndromeDilara Bahceci, Lyndsey L Anderson, Richard C Kevin, et al.
Scientific Reports|July 23, 2021
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrationsLyndsey L Anderson, Maia G Etchart, Dilara Bahceci, et al.
Epilepsy & Behavior : E&B|December 25, 2019
Adolescent behavioral abnormalities in a Scn1a<sup>+/-</sup> mouse model of Dravet syndromeDilara Bahceci, Lyndsey Leigh Anderson, Cassandra Veronica Occelli Hanbury Brown, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 4, 2017
Interactions between cannabidiol and Δ<sup>9</sup>-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathwayStephanie M Todd, Cilla Zhou, David J Clarke, et al.
The Australian and New Zealand Journal of Psychiatry|October 13, 2023
Ensuring the affordable becomes accessible-lessons from ketamine, a new treatment for severe depressionAnthony Rodgers, Dilara Bahceci, Christopher G Davey, et al.
Frontiers in Pharmacology|June 3, 2021
The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the <i>Scn1a</i> <sup></sup> Mouse Model of Dravet SyndromeVaishali Satpute Janve, Lyndsey L Anderson, Dilara Bahceci, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2018
Nrg1 deficiency modulates the behavioural effects of prenatal stress in miceDavid J Clarke, Lala Sarkissian, Stephanie M Todd, et al.
Neuropharmacology|November 25, 2021
The endocannabinoid system impacts seizures in a mouse model of Dravet syndromeLyndsey L Anderson, Peter T Doohan, Nicole A Hawkins, et al.
Drug and Alcohol Dependence|May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international surveyDilara Bahceci, Krista Siefried, Maureen Steele, et al.
Pageof 2